{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:04:00Z","timestamp":1792062240019,"version":"4.4.0"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T00:00:00Z","timestamp":1456444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004448","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T18:49:45Z","timestamp":1456512585000},"page":"e0004448","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Reducing Cost of Rabies Post Exposure Prophylaxis: Experience of a Tertiary Care Hospital in Pakistan"],"prefix":"10.1371","volume":"10","author":[{"given":"Naseem","family":"Salahuddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Aftab","family":"Gohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila","family":"Baig-Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,26]]},"reference":[{"key":"ref1","unstructured":"WHO (2013) WHO Expert Consultation on Rabies. Second report. 0512\u20133054 (Print) 0512\u20133054 (Print). 1\u2013139 p."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1086\/514931","article-title":"Postexposure treatment of rabies in Pakistan","volume":"27","author":"S Parviz","year":"1998","journal-title":"Clin Infect Dis"},{"key":"ref3","first-page":"491","article-title":"Awareness about rabies post exposure prophylaxis in Pakistan among patients and health care workers: results from an Asian Rabies Expert Bureau study","volume":"21","author":"N Salahuddin","year":"2011","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1016\/j.vaccine.2008.09.003","article-title":"Rabies awareness in eight Asian countries","volume":"26","author":"B Dodet","year":"2008","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijid.2004.02.008","article-title":"Rabies deaths in Pakistan: results of ineffective post-exposure treatment","volume":"8","author":"S Parviz","year":"2004","journal-title":"Int J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1016\/j.vaccine.2005.03.007","article-title":"Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine","volume":"23","author":"J Beran","year":"2005","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1016\/j.vaccine.2007.02.075","article-title":"Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997\u20132005","volume":"25","author":"A Dobardzic","year":"2007","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4161\/hv.7.2.14003","article-title":"The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen","volume":"7","author":"H Liu","year":"2011","journal-title":"Hum Vaccin"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1016\/j.vaccine.2006.02.036","article-title":"Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen","volume":"24","author":"A Ambrozaitis","year":"2006","journal-title":"Vaccine"},{"key":"ref10","first-page":"243","article-title":"Utilization of rabies immunoglobulin in seven urban Pakistan emergency rooms","volume":"7","author":"N Salahuddin","year":"2013","journal-title":"Asian Biomed"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e982","DOI":"10.1371\/journal.pntd.0000982","article-title":"Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries","volume":"5","author":"K Hampson","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4103\/0970-0218.69287","article-title":"Intradermal cell culture rabies vaccine: a cost effective option in antirabies treatment","volume":"35","author":"A Rahim","year":"2010","journal-title":"Indian J Community Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2004.09.027","article-title":"Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals","volume":"23","author":"BP Quiambao","year":"2005","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/B978-0-12-387040-7.00013-5","article-title":"Postexposure prophylaxis for rabies in resource-limited\/poor countries","volume":"79","author":"P Shantavasinkul","year":"2011","journal-title":"Adv Virus Res"},{"key":"ref15","year":"1984"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.vaccine.2006.02.027","article-title":"Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity","volume":"24","author":"K Suwansrinon","year":"2006","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00705-005-0493-1","article-title":"Current therapies in rabies","volume":"150","author":"CM Hendekli","year":"2005","journal-title":"Arch Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tmaid.2006.07.001","article-title":"Problems in human rabies post-exposure prophylaxis management","volume":"5","author":"S Tepsumethanon","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00019048-199808000-00008","article-title":"Rabies Postexposure Prophylaxis: When is it Appropriate?","volume":"7","author":"S Kreindel","year":"1998","journal-title":"Infectious Diseases in Clinical Practice"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"383870","DOI":"10.4061\/2011\/383870","article-title":"Human Rabies in the WHO Southeast Asia Region: Forward Steps for Elimination","volume":"2011","author":"G Gongal","year":"2011","journal-title":"Adv Prev Med"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:20:11Z","timestamp":1588994411000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004448"}},"subtitle":[],"editor":[{"given":"Charles E","family":"Rupprecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,26]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004448","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,26]]}}}